ASXL1 mutations are associated with disorders such as Bohring–Opitz syndrome (BOS), acute myeloid leukemia (AML), and embryonic developmental defects [10,11,12,13,14]. Here, ASXL1 is linked to Buschke-Ollendorff syndrome.